Clinical Trial Sponsors Urged To Post Study Design Details Ahead Of Results
This article was originally published in The Pink Sheet Daily
Executive Summary
Vermont Assistant Attorney General Brill says disclosure of clinical trial results on a central registry and posting of a study's design and endpoints before the results would suggest "true disclosure," not off-label marketing.